Form 4: Arteris Director Sells 90,279 Shares Under 10b5-1 Plan

Arteris, Inc. Director Saiyed Atiq Raza sold 90,279 shares of common stock across three transactions in late February 2026, pursuant to a pre-arranged 10b5-1 trading plan.

Summary

• Saiyed Atiq Raza, a Director of Arteris, Inc. (AIP), executed sales of common stock on three separate dates in February 2026.
• A total of 90,279 shares were sold from indirect holdings (Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust).
• The transactions were conducted under a Rule 10b5-1 trading plan adopted by Mr. Raza on November 7, 2025.
• On February 25, 2026, 4,907 shares were sold at a weighted average price of $17.0001 per share.
• On February 26, 2026, 73,610 shares were sold at a weighted average price of $17.1416 per share.
• On February 27, 2026, 11,762 shares were sold at a weighted average price of $17.0079 per share.
• Following these transactions, Mr. Raza beneficially owns 20,839 shares directly and 499,721 shares indirectly through the trust, totaling 520,560 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be a negative signal, the execution under a pre-arranged 10b5-1 plan suggests a planned divestment for personal financial management rather than a reaction to adverse company-specific news.

Negatives

• The sale of a significant number of shares by a director could be perceived negatively by some investors, potentially signaling a lack of confidence or a desire to diversify holdings.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider selling, particularly when executed under a pre-arranged 10b5-1 trading plan, is a common occurrence in the public markets. Such plans allow insiders to sell shares systematically over time, often for personal financial planning, diversification, or tax purposes, without being accused of trading on material non-public information. While the sale itself is a factual event, the existence of a 10b5-1 plan typically mitigates the negative signal that might otherwise be associated with insider selling.

Related Party Transactions

• The shares sold were held indirectly by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which the Reporting Person serves as trustee.

Stakeholder Impact

• Shareholders may interpret the director's sale as a neutral event due to the 10b5-1 plan, or as a minor negative signal if they overlook the pre-planned nature of the transactions.

Key Dates

Recommendation

The insider selling, while notable, was conducted under a pre-arranged 10b5-1 plan, which typically indicates a planned financial move rather than a reaction to new, negative company information. Without additional context on the company's performance or other market factors, this event alone does not warrant a change from a 'hold' position for a seasoned investor. It's a routine insider transaction that doesn't fundamentally alter the investment thesis.

Keywords

Arteris Inc., AIP, Insider Sale, Form 4, Director, Saiyed Atiq Raza, 10b5-1 Plan, Equity Transaction, Stock Sale